Angela Stoyanovitch Joins PBL Assay Science as Vice President, Business Development
People on the Move: January, 2024
Angela Stoyanovitch has joined PBL Assay Science as the Vice President of Business Development. Ms. Stoyanovich is a business development veteran with 19 years of R&D experience and 10 years of success in direct-sales roles at Contract Research Organization (CROs) including Charles River Laboratories, Southern Research, and BioAgilytix. She has matched academic, government, biotech and pharma sponsors with CRO services in a wide variety of therapeutic areas and on numerous technology platforms. She has worked with both small and large molecules with vastly different drug modalities. Ms. Stoyanovitch has supported clients seeking to outsource preclinical, bioanalytical, clinical, and manufacturing services, in early drug discovery and drug development, in accordance with a broad set of regulatory guidelines including GxP standards.
PBL Assay Science is a 30 year leader in the development and supply of specialty immunoassay products and biomarker testing services to basic, drug development, translational, and clinical researchers around the world. PBL supports multinational pharmaceutical companies, biotechnology companies, virtual pharmas, and academic and research institutions. PBL has built a reputation as a high-quality manufacturer of interferon and cytokine proteins and antibodies, as well as pre-packaged, best-in-class interferon and cytokine immunoassay kits.
As a private, family owned company, PBL Assay Science believes people deserve new and improved interventions to treat disease and improve human health, and our vision is to enable the scientific community to overcome challenges through the high-quality solutions we deliver and the trust we inspire.
Ms. Stoyanovitch received her Bachelor’s degree in Biology, with Neuroscience and Religion minors, from Hope College. She started and hosted Legal Drugs Podcast, educating the drug development industry and the general public to encourage safer, faster, and more effective drugs to market. As a speaker and panelist, she highlights innovation through motivational storytelling about the ambitious efforts of biomedical research. Learn more about Angela in her recent BioBuzz 5 Questions With interview.
Connect with Angela on LinkedIn
- About the Author
- Latest Posts
BioBuzz is a community led, experience focused, biotech and life sciences media and events company. BioBuzz highlights regional breaking news, industry professionals, jobs, events, and resources for business and career growth. Their weekly newsletter is subscribed to by thousands in the BioHealth Capital Region and Greater Philadelphia as the go-to for industry updates.
